Global Therapeutic Drug Monitoring Market 2015-2024

May 28, 2015, 17:59 ET from Research and Markets

DUBLIN, May 28, 2015 /PRNewswire/ --

Research and Markets ( has announced the addition of Jain PharmaBiotech's new report "Therapeutic Drug Monitoring - Technologies, Markets, and Companies" to their offering.

     (Logo: )

This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcome. TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to monitoring of drugs of abuse (DoA). Various technologies used for well-known DoA are described.

A section on drug abuse describes methods of detection of performance-enhancing drugs. TDM market is analyzed from 2014 to 2024 according to technologies as well as geographical distribution. Global market for DoA testing was also analyzed from 2014 to 2024 and divided according to the area of application. Unmet needs and strategies for development of markets for TDM are discussed. The report contains profiles of 27 companies involved in developing tests and equipment for drug monitoring along with their collaborations. The text is supplemented with 17 tables, 6 figures and 180 selected references from literature.

Benefits of this report

  • Up-to-date one-stop information on therapeutic drug monitoring
  • Description of 27 companies involved with their collaborations in this area
  • Market analysis 2014-2024
  • Market values in major regions
  • Strategies for developing markets for therapeutic drug monitoring
  • A selected bibliography of 180 publications
  • Text is supplemented by 17 tables and 6 figures

Key Topics Covered:

Executive Summary

1. Introduction
2. Technologies for TDM
3. Drug Monitoring Instruments
4. Applications of TDM
5. Drugs Requiring Monitoring
6. Monitoring of Biological Therapies
7. Monitoring of Drug Abuse
8. Markets for TDM
9. Companies
10. References

For more information visit

Source: Jain PharmaBiotech

Media Contact: Laura Wood, +353-1-481-1716,

SOURCE Research and Markets